David J Waxman

29PUBLICATIONS
17CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Epigenetics (incl. genome methylation and epigenomics)Medical biochemistry - lipidsClinical nutritionMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|May 05, 2026
Disease-associated mutations in the STAT5B SH2 domain reprogram hepatic cholesterol and lipid metabolism.

|Mar 22, 2026
HDI-STARR-seq identifies functional GH-regulated sex-biased hepatocyte enhancers linked to liver metabolism and disease.

Ting-Ya Chang, David J Waxman

|Dec 31, 2025
Single Nucleus MultiOmics Links Novel Transcription Factor Motifs to Murine Hepatic Sex Differences in Chromatin Accessibility and Metabolic Dysfunction-Associated Steatotic Liver Disease.

Kritika Karri, Ting-Ya Chang, Maxim Pyatkov

|Dec 12, 2025
Disease-associated mutations in the STAT5B SH2 domain reprogram hepatic cholesterol and lipid metabolism.

Hye Kyung Lee, Maxim Pyatkov, Oksana Gavrilova

|Nov 24, 2025
HDI-STARR-seq Identifies Functional GH-regulated Sex-Biased Hepatocyte Enhancers Linked to Liver Metabolism and Disease.

Ting-Ya Chang, David J Waxman

|Dec 23, 2024
HDI-STARR-seq: Condition-specific enhancer discovery in mouse liver in vivo.

Ting-Ya Chang, David J Waxman

Pageof 5

Frequent Collaborators

3 joint publications

Tisha Melia

2 joint publications

Bryan J Matthews

2 joint publications

Lothar Hennighausen

1 joint publications

Andy Rampersaud